Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Biodesix Inc (BDSX)

Biodesix Inc (BDSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 138,627
  • Shares Outstanding, K 96,942
  • Annual Sales, $ 49,090 K
  • Annual Income, $ -52,150 K
  • 60-Month Beta 1.14
  • Price/Sales 2.84
  • Price/Cash Flow N/A
  • Price/Book 28.64
Trade BDSX with:

Options Overview Details

View History
  • Implied Volatility 319.61% ( +5.25%)
  • Historical Volatility 54.54%
  • IV Percentile 80%
  • IV Rank 28.69%
  • IV High 966.60% on 01/23/24
  • IV Low 59.34% on 10/09/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 1
  • Volume Avg (30-Day) 10
  • Put/Call OI Ratio 0.40
  • Today's Open Interest 324
  • Open Int (30-Day) 310

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.15
  • Number of Estimates 1
  • High Estimate -0.15
  • Low Estimate -0.15
  • Prior Year -0.24
  • Growth Rate Est. (year over year) +37.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.3200 +8.33%
on 03/22/24
1.9300 -25.91%
on 03/01/24
-0.0950 (-6.23%)
since 02/28/24
3-Month
1.3200 +8.33%
on 03/22/24
2.2100 -35.29%
on 02/05/24
-0.4700 (-24.74%)
since 12/28/23
52-Week
1.0300 +38.83%
on 07/27/23
2.2100 -35.29%
on 02/05/24
-0.2900 (-16.86%)
since 03/28/23

Most Recent Stories

More News
Why Shares of CareDx Are Jumping Friday

The company's diagnostic tests may obtain better coverage from the Centers for Medicare & Medicaid Services.

BDSX : 1.4300 (-0.69%)
CDNA : 10.59 (+0.67%)
GoodRx Holdings, Inc. (GDRX) Tops Q1 Earnings and Revenue Estimates

GoodRx Holdings, Inc. (GDRX) delivered earnings and revenue surprises of 16.67% and 1.16%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

GDRX : 7.10 (+1.28%)
BDSX : 1.4300 (-0.69%)
Natera (NTRA) Reports Q1 Loss, Tops Revenue Estimates

Natera (NTRA) delivered earnings and revenue surprises of -4.24% and 6.88%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

NTRA : 91.46 (+1.11%)
BDSX : 1.4300 (-0.69%)
Progyny (PGNY) Q1 Earnings and Revenues Surpass Estimates

Progyny (PGNY) delivered earnings and revenue surprises of 125% and 5.28%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

PGNY : 38.15 (+0.42%)
BDSX : 1.4300 (-0.69%)
DermTech, Inc. (DMTK) Reports Q1 Loss, Lags Revenue Estimates

DermTech, Inc. (DMTK) delivered earnings and revenue surprises of -13.33% and 4.48%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

DMTK : 0.7020 (-0.99%)
BDSX : 1.4300 (-0.69%)
Biodesix to Report First Quarter 2023 Financial Results on May 11, 2023

Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus on lung disease, announced today that it will release financial results for first quarter ended March 31,...

BDSX : 1.4300 (-0.69%)
Biodesix, Inc. (BDSX) Reports Q4 Loss, Misses Revenue Estimates

Biodesix, Inc. (BDSX) delivered earnings and revenue surprises of -7.69% and 10.23%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

BDSX : 1.4300 (-0.69%)
SHCR : 0.7675 (-8.53%)
Biodesix Announces Fourth Quarter and Fiscal Year End 2022 Results and Highlights

Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced its financial and operating results for the fourth quarter and year ended...

BDSX : 1.4300 (-0.69%)
Biodesix to Participate at Cowen’s 43rd Annual Healthcare Conference

Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, announced today that Scott Hutton, Chief Executive Officer of Biodesix, will participate...

BDSX : 1.4300 (-0.69%)
Biodesix to Report Fourth Quarter and Full Year 2022 Financial Results on March 6, 2023

Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus on lung disease, announced today that it will release financial results for the fourth quarter and year ended...

BDSX : 1.4300 (-0.69%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

Biodesix Inc. is a data-driven diagnostic solutions company. It offers blood-based tests across the lung cancer continuum of care. The company also offers include diagnostic research, clinical research, development, and testing services to biopharmaceutical companies, as well as develops and commercializes...

See More

Key Turning Points

3rd Resistance Point 1.5133
2nd Resistance Point 1.4967
1st Resistance Point 1.4633
Last Price 1.4300
1st Support Level 1.4133
2nd Support Level 1.3967
3rd Support Level 1.3633

See More

52-Week High 2.2100
Fibonacci 61.8% 1.7592
Fibonacci 50% 1.6200
Fibonacci 38.2% 1.4808
Last Price 1.4300
52-Week Low 1.0300

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar